Investor Insight InMed is a pharmaceutical drug development company advancing proprietary small-molecule drugs in Alzheimer’s and ophthalmology, backed by a…
In this exclusive StockCharts video, Julius analyzes sector rotation in US markets, assessing recent damage and potential downside risks. He…